Avax Technologies (Avax Technologies) ROCE % : 0.00% (As of Sep. 2008)

View and export this data going back to . Start your Free Trial

What is Avax Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Avax Technologies's annualized ROCE % for the quarter that ended in Sep. 2008 was 0.00%.

Avax Technologies ROCE % Historical Data

The historical data trend for Avax Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies ROCE % Chart

Avax Technologies Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

ROCE %

Get a 7-Day Free Trial

-134.40

-341.86

-114.04

-187.33

-359.16

Avax Technologies Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
ROCE %	Get a 7-Day Free Trial															-132.93	-168.52	-319.84	-1,153.52	-

Avax Technologies ROCE % Calculation

Avax Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2007 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2007 )		(A: Dec. 2006 )		(A: Dec. 2007 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2007 )		(A: Dec. 2006 )		(A: Dec. 2007 )
	=	-6.693	/	( ( (3.044 - 2.7)	+	(7.377 - 3.994) )	/ 2 )
	=	-6.693	/	( (0.344	+	3.383)	/ 2 )
	=	-6.693	/	1.8635
	=	-359.16 %

Avax Technologies's ROCE % of for the quarter that ended in Sep. 2008 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2008 )		(Q: Jun. 2008 )		(Q: Sep. 2008 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2008 )		(Q: Jun. 2008 )		(Q: Sep. 2008 )
	=	-7.512	/	( ( (2.783 - 3.032)	+	(1.367 - 3.453) )	/ 2 )
	=	-7.512	/	( ( -0.249	+	-2.086 )	/ 2 )
	=	-7.512	/	-1.1675
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2008) EBIT data.

Avax Technologies (OTCPK:AVXT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Avax Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Avax Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avax Technologies (Avax Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210

Website

http://www.avax-tech.com

Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.

Executives

Carl Spana	director	PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A	director	ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines